کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2019589 1542220 2013 13 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Therapeutic uses of prostaglandin F2α analogues in ocular disease and novel synthetic strategies
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی زیست شیمی
پیش نمایش صفحه اول مقاله
Therapeutic uses of prostaglandin F2α analogues in ocular disease and novel synthetic strategies
چکیده انگلیسی

The pharmacological management of glaucoma and ocular hypertension has significantly changed over the last 18 years with the introduction of PGF2α analogues, more specifically latanoprost (6), travoprost (8), bimatoprost (10) and tafluprost (12). Prostanoids are currently the first-line medicines among ocular antihypertensive drugs in terms of efficacy, safety, patient compliance and medical economy. Their ability to effectively reduce intraocular pressure with once-per-day dosing, ocular tolerability comparable to timolol and general lack of systemic adverse effects have made them the mainstay of pharmacological therapy for glaucoma and ocular hypertension all over the world. The present review reports a novel, convergent and highly diastereoselective method for the synthesis of PGF2α analogues from the structurally advanced prostaglandin phenylsulfone (5Z)-(+)-15 and new ω-chain synthons. The biochemistry, clinical efficacy and side effects of four commercially available PGF2α analogues, currently used as first-line agents for reducing intraocular pressure in patients with glaucoma or ocular hypertension, are also discussed.


► A novel, convergent and highly diastereoselective method for the synthesis of PGF2α analogues was developed.
► The biochemistry, clinical efficacy and side effects of four PGF2α analogues are discussed.
► Four antiglaucoma PGF2α analogues have similar IOP-lowering potential and similar degree of the local intolerance.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Prostaglandins & Other Lipid Mediators - Volumes 104–105, July–August 2013, Pages 109–121
نویسندگان
, , , ,